Drugs / Nolpitantium
Nolpitantium
also known as
Besilate de nolpitantium · Besilato de nolpitantio · Nolpitantium besylate · Nolpitantium cation · Nolpitantium ion · Sr-140333
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00232258 | Apr 2005 → Sep 2006 | ulcerative colitis | Sanofi | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nolpitantium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00232258 ↗ |
| Known as | Besilate de nolpitantium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1178725 ↗ |
| Known as | Besilato de nolpitantio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1178725 ↗ |
| Known as | Nolpitantium besylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1178725 ↗ |
| Known as | Nolpitantium cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL1178725 ↗ |
| Known as | Nolpitantium ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1178725 ↗ |
| Known as | Sr-140333 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1178725 ↗ |
| Modality | Small molecule | — CHEMBL1178725 ↗ |